Mufg Securities Emea PLC Charles River Laboratories International, Inc. Transaction History

Mufg Securities Emea PLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 19, 2021	SELL	$294.17 - $371.65 $4.12 Million - $5.2 Million	-14,000 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$249.67 - $299.48 $2.5 Million - $2.99 Million	-10,000 Reduced 41.67%	14,000 $4.06 Million
Q4 2020 Feb 11, 2021	BUY	$222.0 - $252.62 $5.33 Million - $6.06 Million	24,000 New	24,000 $6 Million
Q3 2020 Nov 13, 2020	SELL	$175.56 - $226.45 $7.72 Million - $9.96 Million	-44,000 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$118.84 - $189.72 $1.78 Million - $2.85 Million	-15,000 Reduced 25.42%	44,000 $7.67 Million
Q1 2020 May 12, 2020	BUY	$98.9 - $178.34 $1.72 Million - $3.1 Million	17,400 Added 41.83%	59,000 $7.45 Million
Q4 2019 Feb 11, 2020	BUY	$126.05 - $152.76 $4.29 Million - $5.19 Million	34,000 Added 447.37%	41,600 $6.36 Million
Q3 2019 Nov 12, 2019	BUY	$125.07 - $143.67 $950,532 - $1.09 Million	7,600 New	7,600 $1.01 Million

691

52M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.39B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Mufg Securities Emea PLC, based on Form 13F filings with the SEC.

Stay updated on Mufg Securities Emea PLC with notifications on news.